UPC Analytics
DEEN
Übersicht · Eingereicht:

ACT_40442/2024

FLUID DELIVERY DEVICE WITH TRANSCUTANEOUS ACCESS TOOL, INSERTION MECHANISM AND BLOOD GLUCOSE MONITORING FOR USE THEREWITH

Einstweilige MaßnahmenEinstweilige MaßnahmenMilan LDApplication for provisional measures
Parteien

Kläger

  • Insulet Corporation
Vertreter: null

Beklagte

  • A. Menarini Diagnostics s.r.l.
Vertreter: null
Richter
  • Pierluigi PerrottiPresiding judge
  • Aliza ZanaJudge-rapporteur
  • Anna-Lena KleinLegally qualified judge
  • Uwe SchwengelbeckTechnically qualified judge
Patente
  • EP4201327
CPC-Codes: A61M5/1723, A61M5/1452, A61M5/158, A61B5/14865, A61M5/14244, F04B9/02, A61B5/14532, A61M2230/201, A61M2005/14506, A61M5/14248, B65D83/761, A61M5/3291

Sektor: Packaging & Conveying

Ausgang
PI abgelehnt
Eingereicht:
Erste Entscheidung: 22. Nov. 2024
Sprache:

The Milan Local Division dismissed Insulet Corporation's application for provisional measures against A. Menarini Diagnostics S.r.l. concerning EP4201327 (insulin pump technology), finding the application inadmissible as the auxiliary requests to amend the patent are not permissible in provisional measures proceedings, and also dismissing Menarini's request for security for costs.